Economy3 November 20265 min read
Goyal Pitches USD 1 Trillion Exports and Biopharma Push as Twin Pillars of Viksit Bharat at Delhi Events
Commerce Minister Piyush Goyal addressed students at the Young Leaders Discourse Forum at Kirori Mal College, New Delhi, and later chaired a high-level roundtable on India's biopharma startup ecosystem at Vanijya Bhawan. Taken together, the two events sketched the government's near-term economic ambitions around exports and biotechnology.
The export arithmetic behind the trillion-dollar target
Speaking at Kirori Mal College, Goyal said India had recorded its highest-ever exports of USD 863 billion last year. The government has now set a target of USD 1 trillion for the current year, a 16 per cent jump, even as the International Monetary Fund projected global trade growth at just 1.9 per cent when it released its estimates in April and May. Goyal noted that India could have settled for USD 900 billion, which would itself have been more than twice the IMF's projected global rate, but chose the more ambitious figure. Exports during April to September had already grown 14 per cent to reach USD 480 billion, leaving USD 520 billion to be achieved in the remaining six months, with October also reported as a strong month. The IMF has since revised its global trade growth projection upward to around 3.5 per cent, and Goyal suggested India's performance may have been a contributing factor.
Goyal situated the export push within a broader story of economic transformation. India, he said, had moved from being counted among the 'fragile five' economies to becoming the fastest-growing large economy. Citing a World Bank report on poverty reduction, he noted that around 50 crore people in India had come out of extreme poverty. He attributed this trajectory to India's demographic dividend — an average age below 30 years and a population of 140 crore generating domestic demand — as well as to the trust India had built internationally, with countries across regions seeking preferential and free trade agreements with it.
Addressing students directly, Goyal framed these milestones within the Viksit Bharat 2047 vision, pointing out that today's students would be in their forties when India marks a century of independence. He highlighted the National Education Policy's flexibility provisions, which allow students to change courses, earn credits and move between streams. With 1.1 billion internet users, he added, young people already had access to a large share of global knowledge online.
What the biopharma roundtable put on the table
The second event was organised by the Department for Promotion of Industry and Internal Trade in collaboration with NITI Aayog and the NITI Frontier Tech Hub, bringing together policymakers, industry leaders and biopharma startups under the title "India's Bioeconomy Opportunity: Role of Startups in Driving Innovation and Growth."
Discussions centred on several concrete policy mechanisms. Participants examined a proposed Regulatory Sandbox that would allow startups to test innovations under supervised conditions, alongside a Single Window Clearance system to reduce the compliance burden. The roundtable also took up global regulatory alignment, simplified patent application processes, and expedited customs clearance for laboratory equipment and reagents, a persistent friction point for research-stage companies.
Biopharma SHAKTI, announced in the Union Budget 2026-27, featured prominently as a vehicle for building shared infrastructure including laboratories, testing facilities and clinical trial centres. The idea is to lower costs and help startups scale. Participants also called for stronger inter-ministerial coordination to ensure that policy interventions across departments remain coherent rather than siloed.
Debjani Ghosh, Distinguished Fellow at NITI Aayog, stressed collaboration among startups, industry, academia and government as essential to building a globally competitive bioeconomy. Prof. Gobardhan Das, Member of NITI Aayog, emphasised translating scientific discoveries into commercially viable products as the critical next step. Goyal called for time-bound action on the roundtable's recommendations, arguing that India's scientific capabilities and entrepreneurial talent needed to be leveraged if the country was to lead the global bioeconomy.